Keyword: New York Genome Center
Two AI firms, Insilico Medicine and A2A Pharmaceuticals, launched a joint company aimed at Duchenne muscular dystrophy and other rare orphan diseases.
A technology developed at the New York Genome Center that combines protein and messenger RNA expression measurements in cells has been licensed by BioLegend.
A proof-of-concept study suggests that combines AI and the whole-genome sequencing of tumors could scale precision medicine for cancer.
Johnson & Johnson is set to open a JLABS incubator in New York City to provide a home for 30 startups in a city where space is in short supply.